Sodium Hypochlorite Pulpotomies in Primary Molars: Comparison With Conventional 20% Formocresol Pulpotomies
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · May 13, 2014
Trial Information
Current as of April 30, 2025
Unknown status
Keywords
ClinConnect Summary
As Brief summary.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy, American Society of Anesthesiologists (ASA) Physical Status classification system class I children
- • age between 2.5 and 9 years old
- • with one or more primary molars need pulpotomy treatment
- Exclusion Criteria:
- • children younger than 2.5 or older than 9 years of age
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Hsiao-Hua Chang, phD
Principal Investigator
Assistant Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials